In our study, significant elevation of serum MALAT1 is noted in patients with CHB while only an increasing trend is observed in LC patients.
← all excerpts
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
1
—
—